Recommendations for treating patients with Gaucher disease with emerging enzyme products-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recommendations for treating patients with Gaucher disease with emerging enzyme products

Published:2010-02 Issue:2 Volume:44 Page:84-85
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Cox Timothy M.

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference3 articles.

1. European Medicines Agency (EMEA). Questions and answers on the shortages of Cerezyme and Fabrazyme. 14-8-2009.

2. Force Majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease;Hollak;Blood Cells Mol. Dis.,2009

3. European Medicines Agency (EMEA) Updated temporary treatment recommendations for Cerezyme. Doc. Ref. EMEA/665112/2009 22-10-2009.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Taliglucerase Alfa for the Treatment of Gaucher Disease: A 9-Year Experience;Journal of Inborn Errors of Metabolism and Screening;2022

2. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases;Essays in Biochemistry;2017-12-12

3. Autophagy, lipophagy and lysosomal lipid storage disorders;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2016-04

4. Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease;Journal of Obstetrics and Gynaecology Research;2014-02-26

5. Gaucher Disease and Its Treatment Options;Annals of Pharmacotherapy;2013-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP